Laura Martín de la Fuente

A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer

Ruth Hüttenhain, Meena Choi, Laura Martín de la Fuente et al. · Molecular & Cellular Proteomics · 2019 · 110 citations · Full text

Life Sciences, Biochemistry, Oncology +17

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma

Laura Martín de la Fuente, Sofia Westbom-Fremer, Nicolai Skovbjerg Arildsen et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2020 · 57 citations · Full text

Life Sciences, Immunology, Oncology +17

Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response

Laura Martín de la Fuente, Susanne Malander, Linda Hartman et al. · International Journal of Gynecological Pathology · 2017 · 39 citations · Full text

Medicine, Cancer Biology, Oncology +17

Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method

Nicolai Skovbjerg Arildsen, Laura Martín de la Fuente, Anna Måsbäck et al. · Scientific Reports · 2019 · 23 citations · Full text

Medicine, Gynecology, Oncology +17

High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density

Sara Corvigno, Josefin Fernebro, Josefin Severin Karlsson et al. · Gynecologic Oncology · 2025 · 13 citations · Full text

Medicine, Oncology, Pathology +17